Evolent Health (EVH) Gross Profit (2015 - 2026)
Evolent Health (EVH) posted quarterly Gross Profit of $83.8 million for Q1 2026, down 18.25% year-over-year from $102.5 million in Q1 2025, and down 13.86% quarter-over-quarter from $97.3 million in Q4 2025.
Evolent Health (EVH) Gross Profit (2015 - 2026) Analysis & Trends
Evolent Health's Gross Profit history runs 12 years deep, the most recent figure standing at $83.8 million for Q1 2026.
- In Q1 2026, Gross Profit fell 18.25% year-over-year to $83.8 million; the TTM figure through Mar 2026 stood at $381.2 million (up 4.23% YoY), while the FY2025 annual figure was $399.9 million, up 8.86% from the prior year.
- Gross Profit for Q1 2026 stood at $83.8 million, down from $97.3 million in the prior quarter.
- The five-year high for Gross Profit was $124.4 million in Q3 2023, with the low at $70.2 million in Q2 2022.
- The 5-year median for Gross Profit is $99.8 million (2025), against an average of $95.8 million.
- The sharpest annual moves came in 2023 and 2024: Gross Profit surged 66.87% in 2023, then slumped 35.15% in 2024.
- Evolent Health's Gross Profit stood at $83.1 million in 2022, then rose by 22.35% to $101.6 million in 2023, then fell by 25.5% to $75.7 million in 2024, then increased by 28.45% to $97.3 million in 2025, then retreated by 13.86% to $83.8 million in 2026.
- Business Quant data shows EVH's Gross Profit at $83.8 million in Q1 2026, $97.3 million in Q4 2025, and $99.8 million in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|